1 / 25

VOLUNTARY EU RISK ASSESSMENT FOR LEAD

VOLUNTARY EU RISK ASSESSMENT FOR LEAD. Challenges and Opportunities for the Crystal Industry. Craig Boreiko Waterford, Ireland October 2002. TOPICS. Why a voluntary effort? Components of Official RARs The Voluntary Lead Effort Issues for the Crystal Industry. RECENT LEAD RESTRICTIONS.

jemima
Télécharger la présentation

VOLUNTARY EU RISK ASSESSMENT FOR LEAD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VOLUNTARY EU RISK ASSESSMENT FOR LEAD Challenges and Opportunities for the Crystal Industry Craig Boreiko Waterford, Ireland October 2002

  2. TOPICS • Why a voluntary effort? • Components of Official RARs • The Voluntary Lead Effort • Issues for the Crystal Industry

  3. RECENT LEAD RESTRICTIONS • EU directives • end–of–life vehicles • waste electrical and electronic equipment • construction and demolition waste • Danish lead ban

  4. COMMON THEME • No sound science • out of date information • no assessment of risks • Product restrictions implemented with no demonstrable benefit

  5. WHY A VOLUNTARY RISK ASSESSMENT? • Growing number of restrictions • No sound science • No prospect of official risk assessment

  6. EU RISK ASSESSMENT • Systematic Assessment of risks for Human Health & Environment • >10,000 substances….4 priority lists • Links to EU Risk Management, e.g. • Water Framework Directive • Marketing & Use Directive (EU 76/769) • Technical Guidance Document • Rapporteur • Technical Meeting (TM) of EU Member States

  7. EU RISK ASSESSMENT • Establishes classification (eg CMR) • For human health it evaluates risk • From occupational exposure • For consumer exposure • From indirect exposure via environment • Assesses risk from production and use upon water sediment and soil compartments • Local impacts • Regional impacts

  8. EU RISK ASSESSMENT • Three potential outcomes possible: • Conclusion i: Need additional information • Conclusion ii: No risk • Conclusion iii: Potential risk and risk reduction needs.

  9. A NEW APPROACH • Established EU RAR procedure but no provision for voluntary approach • Key issue – credibility • Extensive discussions with European Commission and Member States • Agreement reached December 2001

  10. POLITICAL AGREEMENT • Agreement reached between • European Commission (DG Enterprise & DG Environment) • European Chemicals Bureau • Dutch Government • other Member States

  11. INDUSTRY LDA International • Overall project management • Collect industry data on occupational exposure / environmental emissions

  12. REVIEWING COUNTRY • The Netherlands • Monitors entire process on behalf of all EU Member States • Review methods & draft RARs • Keep other Member States informed

  13. INDEPENDENT SCIENTIFIC REVIEW PANELS Environment • Prof Colin Janssen (University of Ghent) • Prof Steve McGrath (Rothampstead Institute) • Prof Dominic Di Toro (Manhattan College) • Dr Rene Korenromp (TNO)

  14. INDEPENDENT SCIENTIFIC REVIEW PANELS Health • Prof. Bob Goyer (ex-University of Western Ontario) • Dr Marjorie Smith (University of London) • Dr Lars Gerhardsson (University Hospital, Lund) • Dr. Gerhard Winneke (Heinrich-Heine University) • Dr. Harry Roels (University of Louvain)

  15. INDEPENDENT CONSULTANTS Environment • Dr Patrick Van Sprang (EURAS, Belgium) • Prof Erik Smolders (University of Leuven, Belgium) Health • Dr Craig Boreiko (ILZRO, USA) • Dr Rodger Battersby (EBRC, Germany)

  16. SCOPE Other compounds PbO, Pb3O4 Pb (metal) Pb stabilisers Batteries - vehicles - industrial - motive CablesSheet- roofing - shieldingSolders - electronicsAlloys - vehiclesShot- shooting Glass - crystal - TVs, monitorsCeramics - tableware Plastics - windows - pipes - cables ElectronicsGasolinePaints

  17. OVERALL TIMETABLE

  18. PRIMARY HEALTH ISSUES OF CONCERN • Lead Specific Endpoints • Neurobehavioral (pediatric) • Male and Female Reproduction (occupational) • Neuropsychological (occupational) • Blood pressure (general population)

  19. PRIMARY AT-RISK GROUPS • Children to age 6 • Workers (male and female) • Women of child bearing age in general population?

  20. OCCUPATIONAL EXPOSURE ASSESSMENT • Data collection: • questionnaires tailored to each industry (site inspections, workplace descriptions) • medical surveillance and exposure values • published reviews/assessments

  21. CONSUMER EXPOSURE ASSESSMENT • Screening of published data • Collection of industry data • Determination of relevant exposure pathways/consumer products • Historical vs. current situation

  22. INDIRECT EXPOSURE VIA ENVIRONMENT Interaction with ENV RA: • Regional and local concentrations for soil, water air provided from single source • Dietary intake (predominate for adults) • Soil/dust exposure (predominate for children) • Long-term environmental loading

  23. CRYSTAL INDUSTRY INPUT • Assist in questionnaire development • Contribute occupational exposure data • Contribute environmental emissions data • Provide material flow information • Help address “end of life” and recycling issue

  24. CONSUMER EXPOSURE • Key issue for the crystal industry • Provide data on consumer use patterns • Define performance of modern product • Help establish consumer exposure profile

  25. BENEFITS TO THE CRYSTAL INDUSTRY • Validation of consumer safety • Avoid arbitrary product restrictions • Establish occupational health performance • Establish environmental emissions • Achieve cooperative compliance with new EU Chemicals Policy

More Related